These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 11261747

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
    Navan P, Findley LJ, Jeffs JA, Pearce RK, Bain PG.
    Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pergolide : A Review of its Pharmacology and Therapeutic Use in Parkinson's Disease.
    Markham A, Benfield P.
    CNS Drugs; 1997 Apr; 7(4):328-40. PubMed ID: 27520755
    [Abstract] [Full Text] [Related]

  • 8. High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study.
    Arnold G, Gasser T, Storch A, Lipp A, Kupsch A, Hundemer HP, Schwarz J.
    Arch Gerontol Geriatr; 2005 Apr; 41(3):239-53. PubMed ID: 16029905
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
    Storch A, Trenkwalder C, Oehlwein C, Winkelmann J, Polzer U, Hundemer HP, Schwarz J.
    Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
    [Abstract] [Full Text] [Related]

  • 15. A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide.
    Navan P, Findley LJ, Undy MB, Pearce RK, Bain PG.
    Eur J Neurol; 2005 Jan; 12(1):1-8. PubMed ID: 15613140
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease.
    Molho ES, Factor SA, Weiner WJ, Sanchez-Ramos JR, Singer C, Shulman L, Brown D, Sheldon C.
    J Neural Transm Suppl; 1995 Jan; 45():225-30. PubMed ID: 8748629
    [Abstract] [Full Text] [Related]

  • 18. An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease.
    Lyons KE, Pahwa R.
    Mov Disord; 2009 Oct 30; 24(14):2121-7. PubMed ID: 19768728
    [Abstract] [Full Text] [Related]

  • 19. Switching dopamine agonists in advanced Parkinson's disease: is rapid titration preferable to slow?
    Goetz CG, Blasucci L, Stebbins GT.
    Neurology; 1999 Apr 12; 52(6):1227-9. PubMed ID: 10214748
    [Abstract] [Full Text] [Related]

  • 20. Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease.
    Wong KS, Lu CS, Shan DE, Yang CC, Tsoi TH, Mok V.
    J Neurol Sci; 2003 Dec 15; 216(1):81-7. PubMed ID: 14607306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.